Clinical trial
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With…
NCT00348998 · Virginia Mason Hospital/Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00348998 |
|---|---|
| Title | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer |
| Official title | Pilot Phase II Trial of Bevacizumab in Combination With Hormonal and Radiotherapy in Patients With High-Risk Prostate Cancer |
| Lead sponsor | Virginia Mason Hospital/Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | bevacizumab, bicalutamide, goserelin acetate, radiation therapy |
| Enrollment | 18 |
| Start date | Apr 1, 2006 |
| First posted | Jul 6, 2006 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: